Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Goeran Hajak, University of Regensburg
ClinicalTrials.gov Identifier:
NCT00554658
First received: November 6, 2007
Last updated: October 21, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)